Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Prog. obstet. ginecol. (Ed. impr.) ; 55(5): 243-246, mayo 2012.
Article in Spanish | IBECS | ID: ibc-99865

ABSTRACT

Objetivo. Describir los hallazgos clínicos en un caso de oligoamnios fetal severo asociado a la administración materna de diclofenaco, así como revisar los efectos de los antiinflamatorios no esteroideos (AINE) durante la gestación. Sujetos y métodos. Presentamos un caso clínico que ilustra la complicación descrita en una gestante de 27 semanas con un cólico nefrítico, que desarrolló oligoamnios agudo tras la terapia antiinflamatoria. Resultados. Resolución del oligoamnios tras la supresión de diclofenaco. Conclusiones. El uso de AINE debe realizarse con precaución durante la gestación por sus posibles efectos adversos, entre los que destaca la alteración de la función renal y el cierre prematuro del ductus arterioso (AU)


Objective. To describe the clinical findings in a case of severe fetal oligohydramnios associated with maternal ingestion of diclofenac, as well as to review the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) during pregnancy. Subjects and methods. We present the case of a woman at 27 weeks of pregnancy with nephritic colic who developed acute oligohydramnios after receiving anti-inflammatory treatment. Results. The oligohydramnios resolved after discontinuation of diclofenac. Conclusions. NSAIDs should be used with caution during pregnancy due to possible adverse effects, including impaired renal function and premature constriction of the ductus arteriosus (AU)


Subject(s)
Humans , Female , Pregnancy , Adult , Diclofenac/administration & dosage , Diclofenac/adverse effects , Pregnancy Trimester, Third , Pregnancy Complications/diagnosis , Pregnancy Complications/therapy , Oligohydramnios/diagnosis , Oligohydramnios/therapy , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/analysis , Serum
2.
Prog. obstet. ginecol. (Ed. impr.) ; 51(9): 567-570, sept. 2008. ilus
Article in Es | IBECS | ID: ibc-68571

ABSTRACT

Se denomina embarazo heterotópico a la coexistencia de un embarazo intrauterino con otro extrauterino. Es una entidad infrecuente, que aparece con mayor frecuencia en pacientes sometidas a técnicas de reproducción asistida. Presentamos el caso de una paciente con una gestación heterotópica espontánea que fue diagnosticada mediante ecografía transvaginal. Se realizó una salpingectomía por vía laparoscópica de forma exitosa. La gestación intrauterina cursó sin complicaciones. Realizamos una revisión de la literatura científica de los factores de riesgo de embarazo heterotópico, las técnicas diagnósticas y las opciones terapéuticas


Heterotopic pregnancy is defined as a simultaneous intrauterine and extrauterine pregnancy. It is a rare event, which appears with major frequency in patients submitted to assisted reproductive technologies (ARTs). We reported the case of Patient with one spontaneous heterotopic gestation, that was diagnosed by transvaginal ultrasound. A laparoscopic salpingectomy was realized successfully. The intrauterine pregnancy ended without complications. Review of the published literature about the risk factors for heterotopic pregnancy, the diagnostic tests and the therapeutical options was performed


Subject(s)
Humans , Female , Adult , Pregnancy, Tubal/surgery , Pregnancy, Multiple , Pregnancy Complications/surgery , HIV Infections , Fallopian Tubes/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...